Long COVID Atlas
Text Theme
Note

Education, not medical advice. Do not start, stop, or change any medication or supplement without your own clinician, who knows your history and other medicines.

Treatment · Immunology

Mast cell stabilizers

If overactive mast cells are part of the problem, stabilizing them at the source is the next step beyond antihistamines. Cromolyn and ketotifen aim to stop the cells from firing, and are tried in long COVID when antihistamines alone fall short.

Short version: mast cell stabilizers try to stop the cell firing rather than block one chemical. An add-on with preliminary long COVID evidence, best supervised.

Calming the cell itself

Where antihistamines block one mediator, stabilizers (such as cromolyn or ketotifen) aim to keep the mast cell from degranulating in the first place, reducing the whole spill of mediators.1

One cell, many symptoms triggers:foods, heat, stress, infection mast cell degranulates mediators flood out:histamine, tryptase,prostaglandins flushing, hives, gut upset,palpitations, brain fog
Mast cells are immune cells that store packets of inflammatory chemicals. Ordinary triggers, foods, heat, stress, infection, can make them dump those chemicals (histamine and others) into the body at once. Because mast cells sit near vessels, gut, skin, and nerves, one overreacting cell type can produce flushing, hives, gut upset, palpitations, and fog together.

What the evidence says

Stabilizers and flavonoids (quercetin, luteolin) are used in mast cell activation and have been tried in long COVID, sometimes added when antihistamines are not enough. The long COVID evidence is preliminary.1

preliminary add-on

Practicalities

Oral cromolyn acts mostly in the gut; ketotifen also has antihistamine action. These are generally low-risk but should be combined and supervised by a clinician familiar with mast cell disorders.

What we don't know

Honest about the edges of the evidence. These are open questions, not settled answers.

  • Whether stabilizers beat placebo in long COVID.
  • How they combine with antihistamines.
  • Which patients benefit.

References

Every reference is free to read in full.

  1. Mast cell activation syndrome and long COVID (mediators and stabilizer rationale).

Associated topics

MechanismMast cell activationa treatment tried